Sign in to fuzzto save your conversations, follow your research and come back anytime.
Akums Drugs & Pharma
SectorHealthcare
| Metric (₹ crore) | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 969.89 | 1,181.25 | 1,082.84 | 944.21 | 1,019.11 | 1,033.09 | 1,010.41 | 1,055.55 | 1,024.03 | 1,017.53 | 1,159.59 | 1,157.87 | 1,166.63 |
| Expenses | 1,095.16 | 1,029.42 | 989.4 | 941.22 | 891.1 | 911.9 | 889.05 | 961.63 | 895.06 | 923.05 | 1,012.73 | 1,006.14 | 991.95 |
| EBITDA | -125.27 | 151.83 | 93.44 | 2.99 | 128.01 | 121.19 | 121.36 | 93.92 | 128.97 | 94.48 | 146.86 | 151.73 | 174.68 |
| Depreciation | 29.72 | 30.42 | 31.55 | 33.95 | 34.06 | 34.87 | 44.52 | 40 | 36.92 | 37.86 | 39.65 | 40.12 | 41.07 |
| EBIT | -154.99 | 121.41 | 61.89 | -30.96 | 93.95 | 86.32 | 76.84 | 53.92 | 92.05 | 56.62 | 107.21 | 111.61 | 133.61 |
| Interest | 12.15 | 13.65 | 12.44 | 12.38 | 13.02 | 11.9 | 5.13 | 4.54 | 23.14 | 23.3 | 23.74 | 23.89 | 24.76 |
| Profit Before Tax | -167.14 | 107.76 | 49.45 | -43.34 | 80.93 | 74.42 | 71.71 | 49.38 | 68.91 | 33.32 | 83.47 | 87.72 | 108.85 |
| Net Profit | -187.43 | 32.69 | 195 | -39.47 | 61.21 | 66.65 | 66.31 | 149.61 | 64.69 | 42.7 | 67.67 | 81.34 | 100.98 |
| EPS | -13.16 | 2.22 | 13.21 | -2.89 | 4.21 | 4.37 | 4.26 | 9.64 | 4.15 | 2.66 | 4.33 | 5.53 | 6.53 |
| Metric (₹ crore) | FY15 | FY16 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 71.76 | 89.14 | 28.13 | 130.61 | 31.85 | 176.63 | 498.26 | 465.2 | 1,181.2 |
| Investing Cash Flow | -149.64 | -122.96 | -189.87 | -108.87 | -234.82 | -304.7 | -330.8 | -547.84 | -930.27 |
| Financing Cash Flow | 66.43 | 37.38 | 233.01 | -91.46 | 236.04 | 124.54 | -108.02 | 72.79 | 33.88 |
| Net Cash Flow | -11.45 | 3.56 | 71.27 | -69.72 | 33.07 | -3.53 | 59.44 | -9.85 | 284.81 |
| Metric (₹ crore) | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Equity / Shareholders' Funds | 720.89 | 887.14 | 625.17 | 723.37 | 720.49 | 3,063.61 | 3,331.12 |
| Total Liabilities | 1,357.39 | 1,279.74 | 2,443.88 | 2,543.16 | 2,795.88 | 1,049.83 | 2,115.85 |
| Total Assets | 2,078.27 | 2,166.87 | 3,069.05 | 3,266.53 | 3,516.36 | 4,113.44 | 5,446.96 |